Company profile
CytoCure company profile
CytoCure LLC is an early-stage biopharmaceutical company founded on a novel platform technology to develop anti-cancer drugs that will make therapeutic cancer vaccines more effective. When combined with cancer immunotherapy, CytoCure's drugs will enhance patients' ability to recognize and destroy their own malignant tumors. CytoCure scientists have discovered a process by which tumor cells lose expression of genes encoding immune targets. This process of "antigen silencing" is a common finding among tumors. CytoCure scientists have shown that the loss of these antigens is often due to reversible gene regulation. Proprietary CytoCure technology is based on overcoming tumor-produced factors that induce..... For more information, log in to dureach.com to view the full company profile.
Business identity
- Website
- http://www.cytocure.com/
- Contact email
- [email protected]
- Phone number
- 1-978-232-1243
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00011-00050 employees
- Revenue range
- $1K+
- Founded
- 1999-01-01
Headquarters
- Headquarters
- Beverly, Massachusetts, United States
- Postal code
- 01915
- Country code
- US
- Continent
- North America